Higher Levels of IgG3 Antibodies in Serum, But Not in CSF, Distinguish Multiple Sclerosis From Other Neurological Disorders

Bankoti J, Apeltsin L, Hauser SL, Allen S, Albertolle ME, Witkowska HE, Von Büdingen HC (2014) In multiple sclerosis, oligoclonal bands connect to peripheral B-cell responses. Ann Neurol 75:266–276

CAS  Article  Google Scholar 

Bakshi R, Yeste A, Patel B, Tauhid S, Tummala S, Rahbari R, Chu R, Regev K, Kivisäkk P, Weiner HL, Quintana FJ (2016) Serum lipid antibodies are associated with cerebral tissue damage in multiple sclerosis. Neurol Neuroimmunol Neuroinflamm. 3:e200

Bankoti J, Apeltsin L, Hauser SL, Allen S, Albertolle ME, Witkowska HE, Von Büdingen HC (2014) In multiple sclerosis, oligoclonal bands connect to peripheral B-cell responses. Ann Neurol 75:266–276

CAS  Article  Google Scholar 

Beseler C, Vollmer T, Graner M, Yu X (2017) The complex relationship between oligoclonal bands, lymphocytes in the cerebrospinal fluid, and immunoglobulin G antibodies in multiple sclerosis: Indication of serum contribution PLoS One 12: e0186842

Brandle SM, Obermeier B, Senel M, Bruder J, Mentele R, Khademi M, Olsson T, Tumani H, Kristoferitsch W, Lottspeich F, Wekerle H, Hohlfeld R, Dornmair K (2016) Distinct oligoclonal band antibodies in multiple sclerosis recognize ubiquitous self-proteins. Proc Natl Acad Sci U S A 113:7864–7869

Article  Google Scholar 

Buck, D., Albrecht, E., Aslam, M., Goris, A., Hauenstein, N., Jochim, A., International Multiple Sclerosis Genetics, C., Wellcome Trust Case Control, C., Cepok, S., Grummel, V., Dubois, B., Berthele, A., Lichtner, P., Gieger, C., Winkelmann, J., and Hemmer, B (2013) Genetic variants in the immunoglobulin heavy chain locus are associated with the IgG index in multiple sclerosis. Ann Neurol 73:86–94

Article  Google Scholar 

Damelang T, Rogerson SJ, Kent SJ, Chung AW (2019) Role of IgG3 in Infectious Diseases. Trends Immunol 40:197–211

CAS  Article  Google Scholar 

Delic-Sarac M, Izetbegovic S, Karamehic J, Subasic D, Saban A, Jukic T, Coric J, Panjeta M (2013) Detection methods of immunoglobulin IgG in CSF and serum. Med Arch 67:368–371

Article  Google Scholar 

Delmotte P, Demonty L (1976) Biochemical findings in multiple sclerosis. II. A detailed study of the serum IgA, IgG and IgM levels of 772 MS patients compared with 226 neurological controls. J Neurol 211:135–142

CAS  Article  Google Scholar 

Di Pauli F, Gredler V, Kuenz B, Lutterotti A, Ehling R, Gneiss C, Schocke M, Deisenhammer F, Reindl M, Berger T (2010) Features of intrathecal immunoglobulins in patients with multiple sclerosis. J Neurol Sci 288:147–150

Article  Google Scholar 

Farina G, Magliozzi R, Pitteri M, Reynolds R, Rossi S, Gajofatto A, Benedetti MD, Facchiano F, Monaco S, Calabrese M (2017) Increased cortical lesion load and intrathecal inflammation is associated with oligoclonal bands in multiple sclerosis patients: a combined CSF and MRI study. J Neuroinflammation 14:40

Article  Google Scholar 

Ferreira D, Voevodskaya O, Imrell K, Stawiarz L, Spulber G, Wahlund LO, Hillert J, Westman E, Karrenbauer VD (2014) Multiple sclerosis patients lacking oligoclonal bands in the cerebrospinal fluid have less global and regional brain atrophy. J Neuroimmunol 274:149–154

CAS  Article  Google Scholar 

Fischer-Williams M, Roberts RC (1971) Cerebrospinal fluid proteins and serum immunoglobulins. Occurrence in multiple sclerosis and other neurological diseases: comparative measurement of gamma-globulin and the IgG class. Arch Neurol 25:526–534

CAS  Article  Google Scholar 

Gaiser CN, Johnson MJ, De Lange G, Rassenti L, Cavalli-Sforza LL, Steinman L (1987) Susceptibility to multiple sclerosis associated with an immunoglobulin gamma 3 restriction fragment length polymorphism. J Clin Invest 79:309–313

CAS  Article  Google Scholar 

García-Merino A, Persson MA, Ernerudh J, Díaz-Gil JJ, Olsson T (1986) Serum and cerebrospinal fluid antibodies against myelin basic protein and their IgG subclass distribution in multiple sclerosis. J Neurol Neurosurg Psychiatry 49:1066–1070

Article  Google Scholar 

Gilden DH (2005) Infectious causes of multiple sclerosis. Lancet Neurol 4:195–202

CAS  Article  Google Scholar 

Glynn P, Gilbert HM, Newcombe J, Cuzner ML (1982) Analysis of immunoglobulin G in multiple sclerosis brain: quantitative and isoelectric focusing studies. Clin Exp Immunol 48:102–110

CAS  PubMed  PubMed Central  Google Scholar 

Graner M, Pointon T, Manton S, Green M, Dennison K, Davis M, Braiotta G, Craft J, Edwards T, Polonsky B, Fringuello A, Vollmer T, Yu X (2020). Oligoclonal IgG antibodies in multiple sclerosis target patient-specific peptides. PLoS One 15:e0228883

Greve B, Magnusson CG, Melms A, Weissert R (2001) Immunoglobulin isotypes reveal a predominant role of type 1 immunity in multiple sclerosis. J Neuroimmunol 121:120–125

CAS  Article  Google Scholar 

Grimaldi LM, Maimone D, Reggio A, Raffaele R (1986) IgG1,3 and 4 oligoclonal bands in multiple sclerosis and other neurological diseases. Ital J Neurol Sci 7:507–513

CAS  Article  Google Scholar 

Joseph FG, Hirst CL, Pickersgill TP, Ben-Shlomo Y, Robertson NP, Scolding NJ (2009) CSF oligoclonal band status informs prognosis in multiple sclerosis: a case control study of 100 patients. J Neurol Neurosurg Psychiatry 80:292–296

CAS  Article  Google Scholar 

Karrenbauer VD, Bedri SK, Hillert J, Manouchehrinia A (2021) Cerebrospinal fluid oligoclonal immunoglobulin gamma bands and long-term disability progression in multiple sclerosis: a retrospective cohort study. Sci Rep 11:14987

CAS  Article  Google Scholar 

Kaschka WP, Theilkaes L, Eickhoff K, Skvaril F (1979) Disproportionate elevation of the immunoglobulin G1 concentration in cerebrospinal fluids of patients with multiple sclerosis. Infect Immun 26:933–941

CAS  Article  Google Scholar 

Keir G, Walker RW, Johnson MH, Thompson EJ (1982) Nitrocellulose immunofixation following agarose electrophoresis in the study of immunoglobulin G subgroups in unconcentrated cerebrospinal fluid. Clin Chim Acta 121:231–236

CAS  Article  Google Scholar 

Kennedy PGE, Graner M, Pointon T, Li X, Tanimoto K, Dennison K, Im G, Fringuello A, Zhou W, Graner A, Sillau S, Vollmer T, Yu X (2021) Aberrant Immunoglobulin G Glycosylation in Multiple Sclerosis. J Neuroimmune Pharmacol

Kwon YN, Kim B, Kim JS, Mo H, Choi K, Oh SI, Kim JE, Nam TS, Sohn EH, Heo SH, Kim SB, Park KC, Yoon SS, Oh J, Baek SH, Kim BJ, Park KS, Sung JJ, Jung JH, Kim SJ, Park SH, Waters P, Kim SM (2022) Myelin Oligodendrocyte Glycoprotein-Immunoglobulin G in the CSF: Clinical Implication of Testing and Association With Disability. Neurol Neuroimmunol Neuroinflamm 9

Lambin P, Gervais A, Levy M, Defendini E, Dubarry M, Lebon P, Rouger P, Schuller E (1991) Intrathecal synthesis of IgG subclasses in multiple sclerosis and in acquired immunodeficiency syndrome (AIDS). J Neuroimmunol 35:179–189

CAS  Article  Google Scholar 

Long Y, Gao C, Qiu W, Hu X, Peng F, Lu Z (2013) Antibodies target microvessels in neuromyelitis optica and multiple sclerosis patients. Neurol Res 35:922–929

CAS  Article  Google Scholar 

Losy J, Michałowska-Wender G, Wender M (1992) IgG1-IgG4 subclasses in the cerebrospinal fluid and blood serum and their synthesis in the central nervous system in multiple sclerosis. Neurol Neurochir Pol 26:297–303

CAS  PubMed  Google Scholar 

Lumsden CE (1971) The immunogenesis of the multiple sclerosis plaque. Brain Res 28:365–390

CAS  Article  Google Scholar 

Marsh-Wakefield F, Ashhurst T, Trend S, Mcguire HM, Juillard P, Zinger A, Jones AP, Kermode AG, Hawke S, Grau GE, Hart PH, Byrne SN (2020) IgG3 (+) B cells are associated with the development of multiple sclerosis. Clin Transl Immunology 9:e01133.

Mehta PD (1988) Quantitation of IgG subclasses in cerebrospinal fluid of patients with multiple sclerosis. Ann N Y Acad Sci 540:261–263

CAS  Article  Google Scholar 

Raknes G, Fernandes Filho JA, Pandey JP, Myhr KM, Ulvestad E, Nyland H, Vedeler CA (2000) IgG allotypes and subclasses in Norwegian patients with multiple sclerosis. J Neurol Sci 175:111–115

CAS  Article  Google Scholar 

Salier JP, Glynn P, Goust JM, Cuzner ML (1983) Distribution of nominal and latent IgG (Gm) allotypes in plaques of multiple sclerosis brain. Clin Exp Immunol 54:634–640

CAS  PubMed  PubMed Central  Google Scholar 

Shimizu F, Tasaki A, Sano Y, Ju M, Nishihara H, Oishi M, Koga M. Kawai M, Kanda T (2014) Sera from remitting and secondary progressive multiple sclerosis patients disrupt the blood-brain barrier. PLoS One 9:e92872

Trend S, Jones AP, Cha L, Byrne SN, Geldenhuys S, Fabis-Pedrini MJ, Carroll WM, Cole JM, Booth DR, Lucas RM, Kermode AG, French MA, Hart PH (2018) Higher Serum Immunoglobulin G3 Levels May Predict the Development of Multiple Sclerosis in Individuals With Clinically Isolated Syndrome. Front Immunol 9:1590

Article  Google Scholar 

Vartdal F, Vandvik B (1982) Multiple sclerosis. Electrofocused “bands” of oligoclonal CSF IgG do not carry antibody activity against measles, varicella-zoster or rotaviruses. J Neurol Sci 54:99–107

CAS  Article  Google Scholar 

Vidarsson G, Dekkers G, Rispens T (2014) IgG subclasses and allotypes: from structure to effector functions. Front Immunol 5:520

Article  Google Scholar 

Yu X, Graner M, Kennedy PGE, Liu Y (2020) The Role of Antibodies in the Pathogenesis of Multiple Sclerosis. Front Neurol 11:533388

Zeman AZ, Keir G, Luxton R, Thompson EJ (1996) Serum oligoclonal IgG is a common and persistent finding in multiple sclerosis, and has a systemic source. QJM 89:187–193

CAS  Article  Google Scholar 

Zoehner G, Miclea A, Salmen A, Kamber N, Diem L, Friedli C, Bagnoud M, Ahmadi F, Briner M, Sédille-Mostafaie N, Kilidireas C, Stefanis L, Chan A, Hoepner R, Evangelopoulos ME (2019) Reduced serum immunoglobulin G concentrations in multiple sclerosis: prevalence and association with disease-modifying therapy and disease course. Ther Adv Neurol Disord 12:1756286419878340

CAS  Article  Google Scholar 

留言 (0)

沒有登入
gif